N
GWPH

Natixis’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Natixis’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,597
Closed -$1.86M – 1197
2021
Q1 		$1.86M Sell
8,597
-124,955
-94% -$23.5M 0.01% 710
2020
Q4 		$15.4M Buy
133,552
+15,720
+13% +$1.76M 0.06% 305
2020
Q3 		$11.5M Buy
+117,832
New +$13.6M 0.08% 178

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Natixis's GWPH Position: Q2 2021 in Review

Natixis sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 8,597 shares — an estimated $1.86M sold.

Natixis first reported a position in GWPH in Q3 2020 and held it in 3 quarters. The position peaked at $15.4M in Q4 2020. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Natixis reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Natixis sold 8,597 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.86M.
  • Natixis first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 3 quarters.
  • Natixis's GW Pharmaceuticals Plc American Depositary Shares position peaked at $15.4M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Natixis's 13F filing for Q2 2021, filed 13 Aug 2021.